BIOMEDICAL HIV PREVENTION
SUMMIT december 4 - 5, 2017
NO • LA
Originally known as The National HIV PrEP Summit in 2016, the Summit was reborn in 2017 as the Biomedical HIV Prevention Summit (The Summit) so it could be more inclusive of current biomedical HIV prevention measures. The change in name speaks to the crucial need to foster and start building strength in the synergy needed between PrEP, PEP, TasP and the role of condoms in communities of color. In keeping with this mission, the 2017 Summit reconnected scientists, advocates, health departments, communitybased organizations (CBO’s), industry innovators, insurance providers, health centers, medical providers, and people at risk for HIV infection to cross train and network about best methods to implement prevention programs required to end HIV in those communities most at risk for the virus. The Summit was held December 4-5, 2017 in New Orleans at the Hilton Riverside hotel in downtown New Orleans. Its logo represents the spirit of the meeting which is a collaboration between community-based organizations (CBOs), health departments (HDs), national organizations, and NMAC. We believe that ending AIDS has to be more than a slogan, it requires planning, collaborating, and funding. As a result, we focused this year's Summit to empower and educate attendees on ways they can best develop their own comprehensive biomedical HIV plans to end AIDS. Our movement’s work is shifting from condoms to HIV Care = HIV Prevention. Undetectable = Untransmittable (U=U) has transformed the discussion from People Living with HIV (PLWH) as vectors for spreading the virus to PLWH as fierce leaders who can end the epidemic. U=U gives greater empowerment to PLWH and has the potential to end the isolation and depression that has impacted so many people living with HIV. PrEP is about protecting people who are HIV negative with options beyond condom usage. The HIV community must realize that while PrEP may decrease condom usage, it could potentially increase the rates of other STDs. Despite this risk, NMAC believes that it should not stop the need to promote PrEP access for those populations at risk for HIV. The science is clear, PrEP works and it must be accessible to everyone if we are to see an end to AIDS in America. At the Summit, attendees gained increased knowledge and opportunities for community building that are so desperately needed in addressing the needs of communities that have less access to healthcare and medications. Throughout the duration of the Summit, all attendees gained insight from leaders in the biomedical field of HIV prevention and came away from the program better prepared and empowered to continue their important work of leading with race to ensure access and achieve an end to HIV. 2017 BIOMEDICAL HIV PREVENTION SUMMIT 1
CONFERENCE PROGRAM FORMAT The National HIV PrEP Summit was designed to be an interactive conference allowing participants and opportunity to have real conversations about PrEP and Biomedical Interventions. The program consisted of 32 workshops and 4 plenary sessions. The topics covered were research, skills building, program implementation, and public policy. This year we introduced the Community Corner (pictured below) in the exhibit hall for short impactful discussions around a specific topic or PrEP campaign. The Summit hosted over 1100 registrants. These registrants included PrEP users, medical professionals, health department officials, community administrators, researchers and federal officials.
Pictured above: Stephen Hicks, NCSD presenting in the Community Corner
2017 BIOMEDICAL HIV PREVENTION SUMMIT 2
PLENARIES Plenary sessions are informal in-the-round motivational presentations that encouraged interaction and conversation between the audience and speakers. The plenary schedule and topics were as follows:
Day One: December 4, 2017 Treatment as Prevention, PrEP, and the South Presented by: Gina Brown, Southern AID Coalition; Megan Cannon, Houston Health Department; Latesha Elopre, University of Alabama; Leandro Mena, University of Mississippi Medical Center
The Intersection Between HIV Care and Prevention Presented by: Kenyon Farrow, TheBody.com; Sarit Golub, Hunter College, City Unversity of New York; Rich Wolitski, US Department of Health and Human Services; Luis Gutierrz-Mock, Center of Excellence for Transgender Health
Day Two: December 5, 2017 Race and Biomedical Prevention Presented by:Moctezuma Garcia, Texas State University; Ming Ming Kwan, API Wellness, Derrick Matthews, University of Pittsburgh; Sheldon Raymore, The American Indian Commuity House; Dawn Smith, Centers for Disease Control and Prevention
The Revolution and the New HIV Movement Presented by: Antigone Dempsey, HRSA; Leish McKinley-Beach, SisterLove; Anthony Mills, Men’s Health Foundation; Carlos Rodriguez-Diaz, University of Puerto Rico; Pedro Alsonso Serrano, Hektoen Institute
Â
2017 BIOMEDICAL HIV PREVENTION SUMMIT 3
DEMOGRAPHIC INFORMATION The Summit registered 1100 attendees, scholarship recipients, speakers, sponsors and staff. The following information is the demographical breakdown for the registrants. HIV Status
Unknown 3.66% 28
Negative 74.41% 570
Positive 10.84% 83
Undeclared 11.10% 85
Ethnicity African American or Black
262
American Indian or Alaskan Native
5
Asian
34
Caucasian or White
291
Latinx or Hispanic
132
Native Hawaiian or Pacific Islander
1
Prefer not to disclose
13
Not listed
32 0
50
100
150
200
250
300
350
2017 BIOMEDICAL HIV PREVENTION SUMMIT 4
Gender Idenitity Two Spirit
5
Prefer Not to Disclose
13
MTF or Trans Woman
10
Male
389
Intersex
1
Gender Queer
9
Gender Non‐Conforming
8
FTM or Trans Man
9
Female
370
Androgynous
1
Not Reported
264 0
50
100
150
200
250
300
350
400
450
Age Range 65+
13
55‐64
96
45‐54
168
35‐44
234
25‐34
269
20‐24
31
Not Reported
269 0
50
100
150
200
250
300
Sexual Orientation Not Reported Two Spirit Same Gender Loving Questioning Queer Prefer Not to Disclose Pansexual Not Listed Lesbian Heterosexual Gay Bisexual Asexual
287 4 9 1 33 75 10 8 22 332 273 23 2 0
50
100
150
200
250
300
350
2017 BIOMEDICAL HIV PREVENTION SUMMIT 5
ATTENDEE COMMENTS
Thank you, thank you SO much for this Summit! I attended this year and last year in SF and I was blown away by how much everything has grown in such a short period of time. I was lucky enough to be a panelist who received funding to be here and I am very grateful for the chance to connect with my peers across the county. I work in North FL and more often than not feel very isolated in the work we are doing, but am recharged! This Summit has an intimacy not found anywhere else! Amazing work. LOVE! ‐
Sabrina Cluesman
”Networking opportunities with others in the struggle. Opportunities to see what other agencies nationwide are doing towards ending the epidemic. Open, affirming atmosphere, and straightforward approach with message delivery.”
Great workshops. Learned so much. Future of Prevention on the 5th was the best! ‐
Julie Fitch
“My first summit and the information and dialogue with clinicians, researchers and prevention professionals was amazing.”
– Vaughn O’Neal
– Elton Naswood
2017 BIOMEDICAL HIV PREVENTION SUMMIT 6
EVALUATION QUANTITATIVE DATA
2017 BIOMEDICAL HIV PREVENTION SUMMIT 7
2017 BIOMEDICAL HIV PREVENTION SUMMIT 8
The success of the National HIV PrEP Summit is attributed to many forward thinking, hardworking people who are passionate around changing health outcomes.
2017 BIOMEDICAL HIV PREVENTION SUMMIT 9
THANK YOU SPONSORS
Presenting Sponsor
Champion Sponsor
Benefactor Sponsors
Supporter Sponsor
Ally Sponsor
2017 BIOMEDICAL HIV PREVENTION SUMMIT 10
PROGRAM COMMITEE NMAC would like to extend a special thank you to the 2017 Summit program committee who worked many hours for many months to provide the fully curated program. Brandon Braud New Orleans, LA Elizabeth Crutsinger-Perry Washington State Department of Health, Seattle WA Edwin Corbin-Gutierrez NASTAD, Washington DC Benjamin Di'Costa Chicago, IL Kenyon Farrow TheBody.com, New York, NY Charlene Flash Baylor College of Medicine, Houston, TX Deirdre Grant New York Blood Center, New York, NY Miguel Martinez CrescentCare, New Orleans, LA Rob Newells AIDS Project East Bay, Oakland, CA Asa Radix Callen Lorde, New York, NY Zach Reau NASTAD, Washington, DC Michael Stirratt NIH, Washington, DC Carole Treston Association of Nurses in AIDS Care, Philadelphia, PA Dashawn Usher New York Blood Center, New York, NY Â
2017 BIOMEDICAL HIV PREVENTION SUMMIT 11
Additionally, thank you to the NMAC Staff who collaborated with sponsors, program partners and community to ensure the vision of the Summit came to life. NMAC has dedicated its mission to leading with race to achieve health equity. We look forward to another groundbreaking year of collaborating and innovating.
1000 Vermont Avenue, NW Suite 200 Washington, DC 20005
2017 BIOMEDICAL HIV PREVENTION SUMMIT 12